Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

London TMAU meeting with Prof Liz Shephard
19th Oct 11am - 1pm
St Mary's Hospital
Praed St, Paddington
London W2 1NY
click to read more
more details :

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Tuesday, September 18, 2012

Join NORD and MEBO Research in Opposing Budget Cuts


Under the Budget Control Act of 2011, there is a possibility of an across-the-board funding cuts of approximately 8 percent that could be imposed upon NIH, FDA, and other federal agencies in January 2013. CONGRESS HAS NOT YET REACHED AN AGREEMENT ON A BUDGET DEFICIT REDUCTION PLAN, AND YOU CAN MAKE A DIFFERENCE! It is up to us to let them know that we oppose any budget cuts resulting in the loss of ability to fund new research grants or reduce commitment to existing grants.

The cuts would slice $2.5 billion from a $30 billion budget, resulting in the loss of the ability to fund about 2,300 new grants or reduced commitment to existing grants.
Last week, the White House Office of Budget and Management (OMB) released a report on the possible effects of these funding cuts, known as "sequestration", on federal agencies. The cuts could result in the loss of 1,200 FTEs at FDA alone. They could negate much of the anticipated benefit from this summer's FDA Safety and Innovation Act.

At NIH, the result would be equally devastating. The cuts would slice $2.5 billion from a $30 billion budget, resulting in the loss of the ability to fund about 2,300 new grants or reduced commitment to existing grants.


Support a Balanced Approach to Deficit Reduction

As part of the Budget Control Act of 2011, a budget cut of between 8.5% and 10% of all Federal programs is to take effect at the end of this year. This includes all research funding at NIH, and all regulatory science activities at the FDA, including those made possible by user fees.
Take action now to support a balanced approach to deficit reduction and let your elected officials know that Federal support for rare diseases is important to you.

See NORD'S Alert for additional information

In recent weeks, NORD has been meeting with other organizations concerned about these potential cuts, including the Coalition for Health Funding ( It is our fervent hope that Congress and the President will reach agreement on a deficit reduction plan before January so that the cuts won't be implemented.

But in the meantime, we encourage you to submit a letter to your elected officials through NORD's Legislative Action Center to let your elected officials know that Non-Defense Discretionary (NDD) programs, including medical and scientific research, education, public health and more, have already borne more than their fair share of responsibility for deficit reduction.

We encourage you to personalize your letter by including information about how a rare disease has affected you or your family.


María de la Torre
Founder and Executive Director

A Public Charity
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

Please use your credit card to make your donation to MEBO.

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner

A EURORDIS and NORD Member Organization


Post a Comment